Wind Point Partners (“Wind Point”) and Ascensus Specialties LLC (“Ascensus”) today announced that Ascensus has completed the acquisition of Strem Chemicals, Inc. (“Strem” or the “Company”). Strem is a global leader in high-purity, research-grade catalysts, ligands, organometallics, metal carbonyls and CVD/ALD precursors.
Tags: SOCMA Member News
Lonza Publishes Invitation to the 2021 Annual General Meeting and 2020 Annual and Sustainability Reports
Lonza today announced the publication of its 2020 Annual and Sustainability Reports, as well as its invitation to the 2021 Annual General Meeting (AGM). The event will take place on Thursday, 6 May 2021, at 10:00 a.m. CEST, at the company’s headquarters in Muenchensteinerstrasse 38, 4002 Basel, Switzerland.
Cambrex today announced that it had been recognized across six categories in the annual CMO (Contract Manufacturing Organization) Leadership Awards.
Sun Chemical released its Winter 2021 Regulatory Newsletter for customers which is available for download at www.sunchemical.com/sustainability/regulatory-newsletters.
Archroma, a global leader in specialty chemicals towards sustainable solutions, today announced a strategic partnership with technology innovator CleanKore, aiming to advance sustainable dyeing processes throughout the denim supply chain.
Lonza (with the Specialty Ingredients segment – LSI – reported as discontinued operations) today reported strong sales of CHF 4.5 billion, sales growth of 12.0%5, and CHF 1.4 billion CORE EBITDA, resulting in a margin of 31.2%. The results mainly reflect the Pharma Biotech & Nutrition segment (LPBN), which delivered 12.2%5 sales growth and a CORE EBITDA margin of 32.1%.
In recognition of their tireless work during an incredibly challenging year, Pilot Chemical Corp. is awarding bonuses to each of its 400-plus employees at all operations in the U.S. and Mexico.
Strem Chemicals, Inc. Licenses New Class of Air-Stable Ni(0) Pre-Catalysts from Max-Planck-Institut für Kohlenforschung
STREM Chemicals, Inc. has licensed a technology based on recent developments in the field of Ni(0) (pre)catalysts from the Max-Planck-Institut für Kohlenforschung respectively the associated Studiengesellschaft Kohle mbH.
Capricor Collaborates with Lonza for the Development of CAP-1002, its Cell Therapy Candidate for the Treatment of Duchenne Muscular Dystrophy and Other Indications
Capricor Therapeutics, a clinical-stage biotechnology company focused on the development of the first-in-class cell and exosome-based therapeutics for the treatment and prevention of serious diseases, and Lonza today announced that the companies have entered into an agreement for the development of CAP-1002, Capricor's leading clinical asset using allogeneic cardiosphere-derived cells (CDC) technology for the treatment of Duchenne Muscular Dystrophy (DMD) and complications arising from COVID-19.
Aramco and Baker Hughes (NYSE:BKR) have announced the formation of Novel, a 50/50 Joint Venture (JV) to develop and commercialize a broad range of non-metallic products for multiple applications in the energy sector.